P. Brunhoeber

发表

Immunohistochemistry

E. Elgabry, Lauren B. Murata, Shalini Singh, 2019, Companion and Complementary Diagnostics.

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

L. Staudt, A. Rosenwald, W. Chan, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Automated multiplexing quantum dots in situ hybridization assay for simultaneous detection of ERG and PTEN gene status in prostate cancer.

Yixin Wang, Lei Tang, Wenjun Zhang, 2013, The Journal of molecular diagnostics : JMD.

Determination of Optimum Formalin Fixation Duration for Prostate Needle Biopsies for Immunohistochemistry and Quantum Dot FISH Analysis

N. Palanisamy, S. Tomlins, R. Nagle, 2015, Applied immunohistochemistry & molecular morphology : AIMM.

Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.

L. Rimsza, T. Grogan, J. Teruya-Feldstein, 2012, Blood.

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections

Brian D. Kelly, T. Grogan, H. Tsuda, 2012, Diagnostic Pathology.

Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.

A. Rosenwald, W. Chan, D. Weisenburger, 2013, American journal of clinical pathology.

Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review

K. Dvorak, J. Palting, P. Brunhoeber, 2017, Pathology & Oncology Research.

Low GILT Expression is Associated with Poor Patient Survival in Diffuse Large B-Cell Lymphoma

Martin J. Deymier, W. Klapper, L. Lybarger, 2013, Front. Immunol..

Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies

P. Gibbs, M. Christie, J. Tie, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair–Proficient Stage II Colon Cancer

B. LaFleur, P. Gibbs, J. Desai, 2016, Clinical Cancer Research.

Further references of Galli-Galli disease.

A. Ackerman, P. Brunhoeber, 2008, Journal of the American Academy of Dermatology.

Immunohistochemical analysis of the monoclonal antibody 4B5 in breast tissue expressing human epidermal growth factor receptor 4 (HER4)

Michael C. Sugarman, Julie I. Jay, Heather L Free, 2013, Histopathology.